Prevailing in the face of heart failure U-T San Diego Jaski, medical director of Sharp's Advanced Heart Failure and Clinical Cardiology Program, was recruiting patients for a Phase 2a clinical trial for Mydicar, a genetically targeted enzyme replacement therapy developed by Celladon, a San Diego ... |
